These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30093032)

  • 1. Enhanced cytotoxic and apoptotic potential in hepatic carcinoma cells of chitosan nanoparticles loaded with ginsenoside compound K.
    Zhang J; Wang Y; Jiang Y; Liu T; Luo Y; Diao E; Cao Y; Chen L; Zhang L; Gu Q; Zhou J; Sun F; Zheng W; Liu J; Li X; Hu W
    Carbohydr Polym; 2018 Oct; 198():537-545. PubMed ID: 30093032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micelles modified with a chitosan-derived homing peptide for targeted intracellular delivery of ginsenoside compound K to liver cancer cells.
    Zhang J; Jiang Y; Li Y; Li W; Zhou J; Chen J; Shang Z; Gu Q; Wang W; Shen T; Hu W
    Carbohydr Polym; 2020 Feb; 230():115576. PubMed ID: 31887962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of pH-sensitive carboxymethyl chitosan nanoparticles loaded with ginsenoside Rb1 and evaluation of drug release in vitro.
    An Z; Dong Y; Wang W; Wang J; Wu Z; Wang W; He Y; Bao G
    Int J Biol Macromol; 2024 May; 267(Pt 2):131487. PubMed ID: 38599430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies.
    Mathiyalagan R; Subramaniyam S; Kim YJ; Kim YC; Yang DC
    Carbohydr Polym; 2014 Nov; 112():359-66. PubMed ID: 25129755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
    Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
    Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis.
    Elbaz NM; Khalil IA; Abd-Rabou AA; El-Sherbiny IM
    Int J Biol Macromol; 2016 Nov; 92():254-269. PubMed ID: 27397719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans.
    Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
    Int J Biol Macromol; 2017 Aug; 101():1012-1018. PubMed ID: 28389400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line.
    Sedeky AS; Khalil IA; Hefnawy A; El-Sherbiny IM
    Eur J Pharm Sci; 2018 Jun; 118():103-112. PubMed ID: 29597041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity.
    Ahmed TA
    BMC Pharmacol Toxicol; 2020 Feb; 21(1):14. PubMed ID: 32085802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
    Huang C; Li NM; Gao P; Yang S; Ning Q; Huang W; Li ZP; Ye PJ; Xiang L; He DX; Tan XW; Yu CY
    Drug Deliv; 2017 Nov; 24(1):459-466. PubMed ID: 28219253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
    Bu L; Gan LC; Guo XQ; Chen FZ; Song Q; Qi-Zhao ; Gou XJ; Hou SX; Yao Q
    Int J Pharm; 2013 Aug; 452(1-2):355-62. PubMed ID: 23685116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
    Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
    Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
    Bao X; Gao M; Xu H; Liu KX; Zhang CH; Jiang N; Chu QC; Guan X; Tian Y
    Drug Dev Ind Pharm; 2015; 41(7):1193-203. PubMed ID: 25026246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
    Wei B; He L; Wang X; Yan GQ; Wang J; Tang R
    J Biomater Appl; 2017 Aug; 32(2):206-218. PubMed ID: 28618976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
    Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.